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Polymorphonuclear neutrophilic granulocytes (PMN) have been implicated as playing a role in antiviral
defense. In addition to having phagocytic and cytotoxic activities, PMN may produce an antiviral substance
with interferon (IFN)-like activity. The product, for which the name polyferon (PF) has been coined, is
produced upon direct encounter of PMN with bovine herpesvirus 1 (BHV-1)-infected bovine cells or
membranes thereof. Exposure to purified virus only does not induce PF. The intimate interaction between PMN
and the membranes was also revealed by electron microscopy studies. Bovine cells infected with herpes simplex
virus type 1 could also induce PF production by bovine PMN, whereas cells infected with BHV-2, herpes
simplex virus type 2, equine herpesvirus 1, bovine respiratory syncytial virus, bovine viral diarrhea virus, or
parainfluenza virus 3 were unable to do so. Results obtained in experiments using transfected cells expressing
BHV-1 glycoproteins as well as blocking experiments using BHV-1 glycoprotein-monospecific antibodies
suggested that a combination of both viral product(s) and host cell factor(s) unique to bovine cells is required
for induction of PF production by PMN. PF, which appeared in detectable amounts 12 to 18 h after exposure
ofPMN to the appropriate inducer, could not be neutralized by antibodies to bovine IFN-o, -Ii, and -y. PF may
nevertheless belong to the IFN family of proteins, as indicated by its ability to induce 2',5'-oligoadenyl
synthetase in various cell types that are responsive to bovine IFNs and by its antiviral spectrum. It does,
however, differ from the other cytokines in most immunological characteristics tested so far, including major
histocompatibility complex class II antigen induction, cell migration, and cytotoxicity.
The potential importance of (bovine) polymorphonuclear
neutrophilic granulocytes (PMN) in defense against herpes-
virus infection has been amply demonstrated in in vitro
systems (24, 25). PMN migrate to and accumulate in the
bovine lung in large numbers after respiratory tract infection
with bovine herpesvirus 1 (BHV-1) (5, 20) and are the
predominant cell type in herpetic lesions in several other
species (16, 21, 27). The fact that such uncomplicated
virus-induced inflammatory processes can resolve quickly
suggests that mechanisms other than potentially tissue-
damaging reactions, such as release of reactive oxygen
species or enzymes (26), play a major role in virus contain-
ment and elimination. It has been shown that bovine PMN,
upon stimulation with fragmented herpesvirus-infected cells,
can produce a factor with antiviral, interferon (IFN)-like
properties (25). This finding supports the notion that PMN
are important in antiviral immunity, at least as far as
herpesvirus infections are concerned.
In this communication, we report further on characteriza-
tion of the induction, production, and properties of the
antiviral factor, for which the name polyferon (PF) has been
coined.
MATERIALS AND METHODS
PMN isolation. PMN were procured from the peripheral
blood of healthy Holstein or mixed-breed cattle (age range,
0.5 to 4 years) by hypotonic lysis of erythrocytes after
removal of the buffy coat cells (3). The purity of the PMN
preparations was typically 95% or greater. On some occa-
sions, the cells were isolated by a Percoll (Sigma Chemical
Co., St. Louis, Mo.) density centrifugation protocol (9).
* Corresponding author.
t Journal series no. 74 of the Veterinary Infectious Disease
Organization.
Continuous cell lines, viruses, and production of PMN
stimulants. The following cell lines were used for virus
growth: Madin-Darby bovine kidney (MDBK); Georgia bo-
vine kidney (GBK); porcine kidney; bovine skin fibroblast;
simian MA-104, Vero, and BSC-1; rabbit kidney (RK-13);
HeLa; and murine L418R. The cells were grown in Eagle
minimal essential medium (MEM) with 10% Hyclone fetal
bovine serum (Sterile Systems, Inc., Logan, Utah) or horse
serum (GIBCO Laboratories, Grand Island, N.Y.) and main-
tained in MEM-2% serum.
Viruses used were BHV-1 (strain 108), BHV-2, herpes
simplex virus types 1 and 2 (HSV-1 and -2), equine herpes-
virus, vesicular stomatitis virus (VSV), vaccinia virus re-
combinants expressing BHV-1 glycoprotein I (gI) or gIII,
bovine viral diarrhea virus (cytopathic and noncytopathic),
parainfluenza virus 3, bovine rotavirus, and bovine respira-
tory syncytial virus. In some cases, adaptation of a particu-
lar virus to a heterologous host cell system proved neces-
sary. Usually two to three passages were required in these
instances. Murine LMTK- cells and MDBK cells were
transfected with the genes for BHV-1 gI and glll as de-
scribed previously (14).
Monolayers of the various cell types grown in 100-mm
petri dishes (24-h cultures) were inoculated with each virus
and incubated at 37°C with 5 to 6 ml of maintenance medium
until they showed extensive cytopathology (usually 24 h);
exceptions were cases in which noncytopathic virus types or
transfected cells were used. Adherent cells were scraped
into the medium with a rubber policeman, and the entire
culture was frozen at -70°C. Before use, the thawed culture
preparations were irradiated with UV light to inactivate any
infectious virus. Noninfected control cultures were treated
similarly.
To study the kinetics of expression of the PMN-stimu-
lating component(s), BHV-1 infection of GBK cells was
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terminated at various times postinfection, as indicated in
Results.
Cell-free virus for PMN stimulation was produced as
described above except that cellular debris was removed by
centrifugation at 800 x g for 10 min.
PF induction. A total of 5 x 106 PMN was seeded in 16-mm
wells in MEM-2% fetal bovine serum or in Nutridoma-
supplemented MEM (Boehringer Mannheim Biochemicals,
Indianapolis, Ind.) with or without 60 1d of virus, cell, or
virus-cell stimulant. At least two wells per stimulant type
were established. After incubation at 37°C in an atmosphere
of 5% C02-95% humidified air for 24 h, the culture super-
natants were collected, clarified by centrifugation at 800 x g
for 15 min, filtered through 0.22-,um-pore-size membrane
filters (Millipore Corp., Bedford, Mass.), and stored at
-70°C until tested for antiviral activity.
Measurement of antiviral activity. Inhibition of VSV
plaque formation in GBK cells was used as a standard assay
for quantification of antiviral activity (1). Inhibitory effects
on replication of other virus types were determined in a
similar fashion. On some occasions, antibodies to bovine
IFNs (generously provided by CIBA-GEIGY Ltd., Basel,
Switzerland) were included in the initial cell treatment step
to test for neutralizing effect.
2',5'-Oligoadenyl (2-5A) synthetase induction and measure-
ment. MDBK or GBK cell monolayers were incubated with
various concentrations of PF samples or bovine recombinant
IFNs (rBoIFNs) for 24 h. The PF-treated cells were then
washed, detached by trypsinization, pelleted, and lysed in
buffer (20 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid] buffer [pH 7.5], 5 mM MgCl2, 120 mM
KCl, 7 mM dithiothreitol, 10% [vol/vol] glycerol, 0.5%
Nonidet P-40). Synthetase activity in the cytosol was deter-
mined as described elsewhere (H. Bielefeldt Ohmann, M.
Campos, P. J. Griebel, and L. A. Babiuk, Can. J. Vet. Res.,
in press).
MHC class II antigen induction. MDBK cells were grown
to confluency in 96-well tissue culture plates. Triplicate
cultures received 100 ,ul of a 1/4 dilution of PF sample or 100
U of rBoIFN--y or rBoIFN-a1l per ml and were incubated for
48 h at 37°C in 5% C02-95% air. The cultures were washed,
dried for 1 h, fixed in 20% acetone-0.85% NaCl with 0.05%
bovine serum albumin, dried again for 2 to 3 h, and stored at
-20°C until being stained for MHC class II antigen expres-
sion. Monoclonal antibodies specific for bovine MHC class
II antigens (anti-TH81A or anti-TH14B; VMRD, Inc., Pull-
man, Wash.) were used in an immunocytochemical staining
protocol adapted from a virus antigen detection system as
previously described (7). Evaluation was done by visual
examination of individual culture wells with the aid of an
inverted-light microscope. To test for cross-reactivity of PF
with IFNs, duplicate sets of cultures were set up in which
antibody to rBoIFNs was included.
Electron microscopy. Cultures for PF induction were set
up in polystyrene snap-cap tubes instead of culture plates.
Other cultural conditions were as described above.
At various times after incubation, cultures were termi-
nated by pelleting the cells, discarding the medium, and
replacing the medium with 2.5% glutaraldehyde in 0.1 M
phosphate-buffered saline, pH 7.1. Subsequent processing
for electron microscopy was done as previously described
(7) except that cell pellets were embedded in Epon 812.
Ultrathin sections were examined with the aid of a Philips
electron microscope at 60 kV.
Radiolabeling and SDS-polyacrylamide gel electrophoresis.
PF was biosynthetically labeled with [35S]methionine (Am-
ersham, Oakville, Ontario, Canada) by stimulating PMN
while the cells were cultivated in methionine-free MEM
supplemented with Nutridoma and 35 ,uCi of radiolabeled
methionine per ml. The clarified culture supernatants were
dialyzed overnight at room temperature, mixed with sample
buffer with or without 2-mercaptoethanol, and electro-
phoresed on 10 or 15% sodium dodecyl sulfate (SDS)-
polyacrylamide gels (17) in a Minigel apparatus (Bio-Rad
Laboratories, Richmond, Calif.). After being dried, the gels
were exposed to 3M film (Picker International, Saskatoon,
Saskatchewan, Canada) for 3 to 10 days at -70°C.
Molecular sieve filtration. Supernatants (500 ml) obtained
after BHV-1-GBK stimulation of PMN were sequentially
filtered through Amicon filters with molecular weight reten-
tion points of 10,000, 50,000, and 100,000, using an Amicon
concentrator (Amicon Corp., Danvers, Mass.). The different
molecular weight fractions obtained in this manner were
tested for antiviral activity as described above.
PMN-glycoprotein binding assay. BHV-1-infected GBK
cells were lysed, and the proteins were separated on SDS-
slab gels of 7% polyacrylamide, followed by transfer of the
proteins to nitrocellulose membranes as described elsewhere
(28). Strips 5 mm wide were cut from these membranes and
rinsed in phosphate-buffered saline containing 5 mg of bo-
vine serum albumin per ml (to prevent nonspecific cell
attachment). After being washed, the strips were placed in
flat-bottom dishes, positive side facing up. A single-cell
suspension ofPMN in MEM (2 x 107 cells per ml) was added
to the strips, which were then incubated for 5 h at 37°C with
occasional swirling. Incubation was terminated by three
washes with phosphate-buffered saline followed by staining
with Diff Quick stain (American Scientific Products, McGaw
Park, Ill.).
Immunological effects of PF. PF-containing supernatants
were assayed for cellular cytotoxicity in a standard tumor
necrosis factor (TNF) assay, using L929 cells as target cells
(8). Chemotaxinogenic activity of PF as well as the effect of
PF treatment of PMN or monocytes on the subsequent
migration of the cells toward zymosan-activated serum was
tested by using microchemotaxis chambers as described
previously (13). The effect of PF-containing supernatants on
the blastogenic response of bovine peripheral blood leuko-
cytes to phytohemagglutinin, concanavalin A, or interleukin-
2 was assessed by including various dilutions of test samples
in the standard proliferation assay used in our laboratory (4).
RESULTS
Requirements for induction of PF. In accordance with
previous published findings (25), PMN secreted a product
with virus-inhibiting activity upon exposure to disrupted
BHV-1-infected cells but not upon exposure to equivalent
amounts of purified virus. Furthermore, intimate contact
between the cell-virus stimulant and the PMN was required,
since separation of the PMN from the stimulant by a
semipermeable membrane abolished PF induction (data not
shown). This finding was further corroborated by electron
microscope studies which revealed a probing and adherence
behavior of the PMN via extended pseudopods toward the
cellular fragments (Fig. 1). Actual phagocytosis of cellular
debris or virus was rarely seen, nor did the PMN appear to
probe specifically for mature virus particles or liberated
cytoplasmic organelles. Rather, they seemed attracted by
cell surface membranes from infected cells. Although similar
behavior was occasionally observed in cultures with nonin-
fected control cells, it was notably less common in this
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FIG. 1. Electron micrographs of bovine PMN cultured with BHV-1-GBK preparations. The PMN extend pseudopods out toward
membrane fragments (a and b) and will on some occasions adhere to such fragments (c). Pseudopod probing for virus particles was not
apparent, and phagocytosis of virus and membrane fragments was only rarely seen. Bars: a, 0.5 ,um; b, 0.5 ,um; c, 1.0 p.m.
..
.-I
..I .:. s
.
a
1a
. ~
~~~~~~~~~~~
^
J. VIROL.
I
t
t 1.
1.
:,I i
f.,,
 o
n
 N
ovem
ber 5, 2015 by University of Queensland Library
http://jvi.asm.org/
D
ow
nloaded from
 
NEUTROPHIL-DERIVED ANTIVIRAL PROTEIN 1919
r
FIG. 1-Continued.
culture type. These findings suggested that a virus-specified
product(s), expressed on the cell surface during infection,
was an essential component for induction of PF. The com-
ponent(s) necessary for PF induction was also expressed on
HSV-1-infected MDBK cells but not by cells infected with
other herpesviruses or other bovine viruses (Table 1).
To further explore this aspect, several approaches were
taken. Viral proteins separated by nonreducing SDS-poly-
acrylamide gel electrophoresis were transferred to nitrocel-
lulose membranes by electroblotting. Strips cut from these
membranes were incubated with suspensions of PMN in
culture medium on a rocking table at 37°C for 5 h. Staining of
the washed strips as described in Materials and Methods
revealed an area of cell adherence corresponding to a protein
in the molecular weight range of 60,000 to 70,000. Since this
method did not allow for further distinction between several
BHV-1 proteins known to be within this molecular weight
range (22, 29), we tried to inhibit production of PF by
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TABLE 1. Virus and host cell specificity of polyferon induction
Stimulant Ar
Virus Cell
a
Equine herpes-
virus 1
HSV-1
HSV-2
BHV-1
BHV-2
BHV-1
BHV-1
HSV-1
Vacc-BHVgl'
BHV-1
Vacc-BHVgIlII
LSV2neo (LMTK-)
LSV2gI
LRSVgIlI
LRSVgl
LRSVgIII
MDBK
MDBK
MDBK
MDBK
MDBK
MDBK
Porcine kidney
GBK
GBK
GBK
GBK
Bovine skin fibro-
blasts
Bovine skin fibro-
blasts
Bovine skin fibro-
blasts
MA-104
BHV-1 MA-104
HSV-1 MA-104
Vero
BHV-1 Vero
HSV-1 Vero
RK-13
BHV-1 RK-13
HSV-1 RK-13
- HEp-2
BHV-1 HEp-2
HSV-1 HEp-2
HeLa
BHV-1 HeLa
HSV-1 HeLa
L929
BHV-1 L929
'
-, No antigen or activity.
b NT, Not tested.
nti-VSV 2-5A synthetase
~titVer activity (cpm/2
x 106 test cells)
3,143
1,221
682
2,044
746
670
542
647
64 12,316
- 4,396
128 75,102
852
- NTb
- NT
64 NT
4-128 NT
- NT
NT
32
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
<4
4-8
<4
<4
<4
' Vaccinia virus recombinant expressing BHV-1 gpl or gpIII.
including glycoprotein-monospecific rabbit sera in the cul-
tures during induction. A rabbit serum to the bovine rotavi-
rus protein VP6 was included as negative control. Antibod-
ies directed against gIV and gI (equivalent to HSV gD and
gB) completely abolished induction of PF, whereas an anti-
body to glll (equivalent to HSV gC) had some inhibitory
activity (Table 2).
These results suggested that at least gI and gIV and
possibly glll are involved in the induction of PF. To further
explore the possible role of glll in PF induction, either
murine LMTK- or MDBK cells transfected with the glll
gene (14) were used as stimulants. Both cell types express
glll on the cell surface after transfection (14). Cells trans-
fected with a control plasmid only served as negative con-
trols, and cells transfected with the gI gene were used as
potential positive controls. None of these cell preparations
could induce PF production, whereas glll- and gI-trans-
fected MDBK cells subsequently infected with BHV-1 and
TABLE 2. Effect of monospecific rabbit antibodies to BHV-1
glycoproteins on PF production by bovine PMN"
Antibody Specificity Antiviral titer" in given expt
codeb of antibody' 1 2 3
Nil 256 64 64
B gI 0 0 0
D gI 0 0 0
F gI 64 128 64
G gI 0 0 0
N gllI 32 32 32
P gll 32 128 32
Q gll 64 32 8
251 gIV1 0 0 0
253 gIV 0 0 0
Anti-VP6 BRV VP6 NTe 64 128
"Results from three representative experiments.
"Antibodies were kindly provided by S. van den Hurk, Veterinary Infec-
tious Disease Organization (see references 29 and 30).
'Glycoproteins are from BHV-1; BRV, bovine rotavirus.
dAs determined by inhibition of VSV plaque formation GBK cells (1).
'NT, Not tested.
NT undergoing a productive inifection could (data not shown).
Therefore, if gIII is involved in PF induction, it must be
NT present in combination with other viral, and perhaps host,
components.
Murine LMTK- cells underwent an abortive infection
NT only with BHV-1 and therefore were unable to induce PF
NT production by PMN (Table 1). This led us to question
NT whether a host cell component(s) could also be involved in
NT the induction signal. To explore this aspect, a number of cellNT lines derived from different species were infected withNT
NT BHV-1 or HSV-1 and used as stimulants. Only cells of
NT bovine origin could give rise to the stimulatory component
NT (Table 1), which suggested that the stimulatory factor is
NT made up of a host cell membrane constituent (antigen)
NT specific for bovine cells, in association with virus-specified
NT proteins, probably including gIV. BHV-1-induced plasma
NT membrane modifications sufficient to stimulate PF produc-NT tion arose within the first 8 h of virus infection (Table 3).
NT Biological properties of PF. To determine whether PF was
NT related to any of the hitherto characterized bovine IFNs or
TNF-oa, the antiviral and immunological effects of PF were
further explored. Compared with the antiviral activity
against VSV, PF was less effective against BHV-1 and -2 but
had comparable activity against parainfluenza virus 3, bo-
TABLE 3. Relationship between BHV-1 replication in bovine
cells and PF inductive activity
Time (h) after Anti-VSV
BHV-1 infection" activity6
0.<4
2
4
6.<4
8 8-16
11.
15 16
22.32- 4
4. 16-128
" BHV-1-infected cell cultures were terminated at the times indicated and
prepared as described in Materials and Methods.
6 PMN were incubated with the virus-cell preparations for 24 h, followed by
quantification of antiviral activity in the culture supernatant.
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TABLE 4. Antiviral activity of PF against bovine,
human, and equine viruses,"
Virus Antiviral
titer
VSV ............................................. 128
BHV-1 ............................................. 16
BHV-2 ............................................. 16-32
Equine herpesvirus 1 ............................................. <4
Parainfluenza virus 3 ............................................. 128
Bovine viral diarrheal virus ......................................... 64-128
Bovine respiratory syncytial virus ................................ 32-64
HSV-1 ............................................. 128
HSV-2 ............................................. <4
a GBK cells were pretreated for 24 h with a dilution row of a PF preparation
followed by infection with the viruses listed. The antiviral titer was deter-
mined as the reciprocal of the dilution that caused 50% or more inhibition of
viral replication in duplicate cultures.
vine viral diarrhea virus, and HSV-1 (Table 4). Equine
herpesvirus 1 and HSV-2 appeared to be resistant to the
inhibitory effect of PF. This spectrum of antiviral efficacy
resembles the spectrum described for bovine IFN (2, 10).
Furthermore, PF appeared to be an efficient inducer of
2-5A synthetase, one of the pathways in the viral inhibition
exerted by IFNs (19) (Table 1; Fig. 2 and 3). The 2-5A
synthetase induction capacity of PMN supernatants fol-
lowed the kinetics of development of antiviral activity as
detected by inhibition of virus replication (Fig. 2), but the
enzyme-inducing activity could not be inhibited by antibody
to bovine IFN-a1l (Fig. 3), IFN-3, or IFN-y (not shown).
Furthermore, PF could not induce MHC class II antigen
expression on nonlymphoid bovine cells, whereas IFN--y and
TNF-ao could (6) (Table 5).
PF also differed from bovine IFN-ot1l,
-1, and -y as well as
TNF-a in other immunological parameters (Table 5). Thus,
PF does not possess cytotoxic activity, it can function as a
chemoattractant to bovine PMN and monocytes, and it does
not affect the chemotaxis of the cells toward other chemoat-
tractants. However, like the other four cytokines, PF does
appear to have a dose-dependent suppressive effect on
interleukin-2-induced proliferation of bovine T cells (sum-
marized in Table 5; 4 and data not shown).
Physical properties of PF. When PF was produced in
cultures supplied with 35S-labeled methionine and analyzed
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FIG. 2. Kinetics of induction and production of PF by bovine
PMN stimulated with BHV-1-GBK, as evaluated by antiviral and
2-5A synthetase-inducing capacity. (Details of the assays are given
in Materials and Methods.)
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FIG. 3. Induction of 2-5A synthetase activity in MDBK cells by
PF and attempts to block this inductive activity with rabbit antibody
to rBoIFN-al1 (2-5A synthetase induction by rBoIFN-oa1l func-
tioned as a positive control for the system). Results are for tests in
three animals on independent occasions.
by SDS-polyacrylamide gel electrophoresis and autoradiog-
raphy, a protein with a molecular weight of approximately
90,000 became specifically labeled (Fig. 4). By membrane
filtration, it was found that the antiviral activity was retained
with a cutoff molecular weight of 100,000. However, this
method has a margin of +10 to 15% on molecular weights.
An antibody raised to the concentrated product was found to
react with a protein with a molecular weight of approxi-
mately 90,000 when tested by immunoblotting and to inhibit
the antiviral activity of PF preparations (data not shown).
Attempts to purify the PF by fast protein or high-perfor-
mance liquid chromatography have so far been unsuccessful,
since the antiviral activity is lost during purification.
DISCUSSION
This study confirms and extends previously published
work on the herpesvirus-induced antiviral peptide produced
by PMN (25). Corroboration of the IFN-like nature of the
product, PF, was obtained by demonstration of the antiviral
TABLE 5. Characterization of PF
Feature or function IFN-a/3 IFN-y TNF-oa PF
MHC class II antigen induc- - + +
tion on nonlymphoid cells"
Cellular cytotoxicity (L929)' - - +
Chemotaxinogen - - - +
(monocytes, PMN)'
Suppression of chemotaxis" + + +
Suppression of proliferation + + + +
of interleukin-2-dependent
T cells
" Nonlymphoid cells consisted of bovine endothelial. epithelial, and fibro-
blastoid cells (6). PF treatment was for 48 to 72 h.b As determined in a 5'Cr release assay (8).
PF was used as the chemoattractant and compared with zymosan-
activated serum (positive control) and nonactivated serum or medium from
nonstimnulated PMN (negative controls).
" Monocytes and PMN were pretreated for 1 to 3 h with PF before being
used in the assay with zymosan-activated serum as the chemoattractant.
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FIG. 4. Autoradiogram of proteins produced by PMN in the
presence of [35S]methionine during a 24-h stimulation with BHV-
1-GBK or noninfected GBK cells. The culture supernatants were
concentrated by lyophilization and reconstituted to 10 times original
volume with water, followed by extensive dialysis and SDS-poly-
acrylamide gel electrophoresis. A protein with a molecular weight of
approximately 90,000 appeared in the supernatant from BHV-
1-GBK-stimulated PMN cultures (lane a; arrow) but not in GBK-
stimulated PMN cultures (lane b). Lane c, BHV-1-GBK without
cells; lane d, medium control.
spectrum and 2-5A synthetase-inducing capability (19;
Bielefeldt Ohmann et al., in press). However, as previously
concluded (25), PF differs both antigenically and with re-
spect to immunofunctional properties from the hitherto
described bovine IFN-ot1l, -P, and --y as well as from TNF-a.
It also appears to have an unusually high molecular weight:
approximately 90,000 versus 17,000 to 25,000 for most other
cytokines (for review, see M. J. P. Lawman, M. Campos, H.
Bielefeldt Ohmann, P. Griebel, and L. A. Babiuk, Compr.
Biotech., in press). However, there is precedence for such
divergences. Duc-Goiran et al. (12) described several un-
usual IFNs with molecular weights of 26,000 to 80,000 that
were induced in human amniotic membranes. In addition,
these IFNs had unusual antigenic properties. It was specu-
lated that these IFN species may have resulted from fusion
of originally separated IFN-ot and -,B species, either at the
gene level or during or after transcription. Alternatively,
they could represent products of currently unrecognized
genes (12). We cannot at present consider such possibilities
for PF, since it has not been possible to establish an
antigenic relationship with any of the hitherto characterized
bovine IFNs.
The molecular weight as well as functional properties of
PF distinguish it from other PMN-derived antimicrobial
factors, notably the defensins, a group of cationic peptides
with molecular weights of 3,500 to 7,500 (11, 18, 32). These
proteins appear to have antiherpesvirus activity through a
mechanism that involves direct neutralization and inactiva-
tioh of various herpesviruses but not nonenveloped viruses
(11, 18, 32). PF does not have a direct effect on viruses and
also appears to have an antiviral spectrum wider than that of
the defensins. In addition, the herpesviruses seem to be the
virus types more resistant to the antiviral effect of PF (Table
4), a feature shared with the IFNs (1).
From the evidence obtained in this study it seems that a
membrane modification involving a host cell determinant(s)
as well as one or more virus-specified virus determinants is
involved in the activation of PMN to produce PF. The
indications that the virus-specified component of the stimu-
lation complex consists of gI and gIV (HSV gB and gD
equivalents) were derived from the findings that gI- and
gIV-specific antibodies could completely abolish stimula-
tion. The fact that HSV-1 is an equally good stimulant for
bovine PMNs suggests that gI is an important component of
the stimulation complex, since it is the glycoprotein with
greatest homology between the two viruses, whereas ex-
ceedingly limited homology exists on the amino acid level
between gIV (BHV-1) and HSV-1 gD (23, 31; T. Zamb and
L. A. Babiuk, manuscript in preparation).
Although adherence (i.e., cell-cell binding) is a well-
described property of PMN and is essential for the inflam-
matory activities of these cells by preceding migration to and
accumulation in perturbed tissues (15), very little is known
about specific receptors for tissue components on PMN.
Adherence to cell surfaces is usually considered a nonspe-
cific epiphenomenon of activation. However, the results of
this work indicate that PMN can exhibit specific recognition
of structural and antigenic components on cells. Not only is
this binding specific for a foreign, introduced antigen, i.e.,
the herpesvirus-specified protein(s) on the cell membrane,
but it also involves the recognition of a species-specific cell
membrane component(s). Alternatively, the PMN react to a
virus-induced modification of the cell membrane which
occurs only in cells of bovine origin. It could also be
speculated whether mechanisms similar to those proposed
for the CDw18 complex involvement in human PMN adher-
ence to endothelial cells (15) might be involved. However,
since characterization of the CDw18 equivalent in bovine
cells as well as of minor BHV-1 proteins is still lacking, it is
presently not feasible to test this possibility. Nevertheless,
the system presented here, i.e., interaction between PMN
and cell surface membranes of herpesvirus-infected cells,
holds promise for providing a valuable system with which to
study basic aspects of cell-cell interactions. Furthermore,
the elucidation of interactions between PMN and virus-
infected cells should add to the understanding of the patho-
genesis of the diseases caused by these viruses and may
thereby provide further means to regulate immunological
and immunopathological processes.
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